Transcription	O
of	O
the	O
hypersensitive	B-DNA
site	I-DNA
HS2	I-DNA
enhancer	I-DNA
in	O
erythroid	B-cell_type
cells	I-cell_type
.	O

In	O
the	O
human	B-DNA
genome	I-DNA
,	O
the	O
erythroid-specific	B-DNA
hypersensitive	I-DNA
site	I-DNA
HS2	I-DNA
enhancer	I-DNA
regulates	O
the	O
transcription	O
of	O
the	O
downstream	B-DNA
beta-like	I-DNA
globin	I-DNA
genes	I-DNA
10-50	B-DNA
kilobases	I-DNA
away	O
.	O

The	O
mechanism	O
of	O
HS2	B-DNA
enhancer	I-DNA
function	O
is	O
not	O
known	O
.	O

The	O
present	O
study	O
employs	O
RNA	O
protection	O
assays	O
to	O
analyze	O
the	O
transcriptional	O
status	O
of	O
the	O
HS2	B-DNA
enhancer	I-DNA
in	O
transfected	B-DNA
recombinant	I-DNA
chloramphenicol	I-DNA
acetyltransferase	I-DNA
(	I-DNA
CAT	I-DNA
)	I-DNA
plasmids	I-DNA
.	O

In	O
erythroid	B-cell_line
K562	I-cell_line
cells	I-cell_line
in	O
which	O
the	O
HS2	B-DNA
enhancer	I-DNA
is	O
active	O
,	O
the	O
HS2	B-DNA
sequence	I-DNA
directs	O
the	O
synthesis	O
of	O
long	O
enhancer	O
transcripts	O
that	O
are	O
initiated	O
apparently	O
from	O
within	O
the	O
enhancer	B-DNA
and	O
elongated	O
through	O
the	O
intervening	O
DNA	O
into	O
the	O
cis-linked	B-DNA
CAT	I-DNA
gene	I-DNA
.	O

In	O
nonerythroid	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
in	O
which	O
the	O
HS2	B-DNA
enhancer	I-DNA
is	O
inactive	O
,	O
long	B-RNA
enhancer	I-RNA
transcripts	I-RNA
are	O
not	O
detectable	O
.	O

Splitting	O
the	O
HS2	B-DNA
enhancer	I-DNA
between	O
two	O
tandem	B-DNA
Ap1	I-DNA
sites	I-DNA
abolishes	O
the	O
synthesis	O
of	O
a	O
group	O
of	O
long	B-RNA
enhancer	I-RNA
transcripts	I-RNA
and	O
results	O
in	O
loss	O
of	O
enhancer	O
function	O
and	O
transcriptional	O
silencing	O
of	O
the	O
cis-linked	O
CAT	O
gene	O
.	O

In	O
directing	O
the	O
synthesis	O
of	O
RNA	B-RNA
through	O
the	O
intervening	O
DNA	B-DNA
and	O
the	O
gene	O
by	O
a	O
tracking	O
and	O
transcription	O
mechanism	O
,	O
the	O
HS2	B-DNA
enhancer	I-DNA
may	O
(	O
i	O
)	O
open	O
up	O
the	O
chromatin	B-DNA
structure	I-DNA
of	O
a	O
gene	B-DNA
domain	I-DNA
and	O
(	O
ii	O
)	O
deliver	O
enhancer	B-protein
binding	I-protein
proteins	I-protein
to	O
the	O
promoter	O
sequence	O
where	O
they	O
may	O
stimulate	O
the	O
transcription	O
of	O
the	O
gene	O
at	O
the	O
cap	B-DNA
site	I-DNA
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

89	NULL
,	NULL
pp	NULL
.	NULL

11219-11223	NULL
,	NULL
December	NULL
1992	NULL
Biochemistry	NULL
Transcription	NULL
of	NULL
the	NULL
hypersensitive	NULL
site	NULL
HS2	NULL
enhancer	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
enhancer	NULL
function	NULL
/long	NULL
enhancer	NULL
transcripts/Apl	NULL
sites/RNA	NULL
protection	NULL
assays	NULL
)	NULL
Dorotuy	NULL
TuaN*t	NULL
,	NULL
Summing	NULL
Kong*	NULL
,	NULL
anp	NULL
KennEtH	NULL
Hut	NULL
*Harvard-Massachusetts	NULL
Institute	NULL
of	NULL
Technology	NULL
Division	NULL
of	NULL
Health	NULL
Sciences	NULL
and	NULL
Technology	NULL
,	NULL
and	NULL
*Center	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Massachusetts	NULL
Institute	NULL
of	NULL
Technology	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
02139	NULL
Communicated	NULL
by	NULL
James	NULL
Bonner	NULL
,	NULL
August	NULL
25	NULL
,	NULL
1992	NULL
ABSTRACT	NULL
In	NULL
the	NULL
human	NULL
genome	NULL
,	NULL
the	NULL
erythroid-specific	NULL
hypersensitive	NULL
site	NULL
HS2	NULL
enhancer	NULL
regulates	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
downstream	NULL
3-like	NULL
globin	NULL
genes	NULL
10-50	NULL
kilobases	NULL
away	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
HS2	NULL
enhancer	NULL
function	NULL
is	NULL
not	NULL
known	NULL
.	NULL

The	NULL
present	NULL
study	NULL
employs	NULL
RNA	NULL
protection	NULL
assays	NULL
to	NULL
analyze	NULL
the	NULL
transcriptional	NULL
status	NULL
of	NULL
the	NULL
HS2	NULL
enhancer	NULL
in	NULL
transfected	NULL
recombinant	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
plasmids	NULL
.	NULL

In	NULL
erythroid	NULL
K562	NULL
cells	NULL
in	NULL
which	NULL
the	NULL
HS2	NULL
enhancer	NULL
is	NULL
active	NULL
,	NULL
the	NULL
HS2	NULL
sequence	NULL
directs	NULL
the	NULL
synthesis	NULL
of	NULL
long	NULL
enhancer	NULL
transcripts	NULL
that	NULL
are	NULL
initiated	NULL
apparently	NULL
from	NULL
within	NULL
the	NULL
enhancer	NULL
and	NULL
elongated	NULL
through	NULL
the	NULL
intervening	NULL
DNA	NULL
into	NULL
the	NULL
cis-linked	NULL
CAT	NULL
gene	NULL
.	NULL

In	NULL
nonerythroid	NULL
HL-60	NULL
cells	NULL
in	NULL
which	NULL
the	NULL
HS2	NULL
enhancer	NULL
is	NULL
inactive	NULL
,	NULL
long	NULL
enhancer	NULL
transcripts	NULL
are	NULL
not	NULL
detectable	NULL
.	NULL

Splitting	NULL
the	NULL
HS2	NULL
enhancer	NULL
between	NULL
two	NULL
tandem	NULL
Apt	NULL
sites	NULL
abolishes	NULL
the	NULL
synthesis	NULL
of	NULL
a	NULL
group	NULL
of	NULL
long	NULL
enhancer	NULL
transcripts	NULL
and	NULL
results	NULL
in	NULL
loss	NULL
of	NULL
enhancer	NULL
function	NULL
and	NULL
transcriptional	NULL
silencing	NULL
of	NULL
the	NULL
cis-linked	NULL
CAT	NULL
gene	NULL
.	NULL

In	NULL
directing	NULL
the	NULL
synthesis	NULL
of	NULL
RNA	NULL
through	NULL
the	NULL
intervening	NULL
DNA	NULL
and	NULL
the	NULL
gene	NULL
by	NULL
a	NULL
tracking	NULL
and	NULL
transcription	NULL
mechanism	NULL
,	NULL
the	NULL
HS2	NULL
enhancer	NULL
may	NULL
(	NULL
i	NULL
)	NULL
open	NULL
up	NULL
the	NULL
chromatin	NULL
structure	NULL
of	NULL
a	NULL
gene	NULL
domain	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
deliver	NULL
enhancer	NULL
binding	NULL
proteins	NULL
to	NULL
the	NULL
promoter	NULL
sequence	NULL
where	NULL
they	NULL
may	NULL
stimulate	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
at	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

In	NULL
seeking	NULL
to	NULL
identify	NULL
the	NULL
cis	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
human	NULL
globin	NULL
genes	NULL
(	NULL
5'-s-°y-Ay-8-8-3	NULL
'	NULL
)	NULL
,	NULL
this	NULL
laboratory	NULL
(	NULL
1	NULL
)	NULL
and	NULL
others	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
have	NULL
mapped	NULL
four	NULL
erythroid-specific	NULL
and	NULL
developmentally	NULL
stable	NULL
DNase	NULL
I-hypersensitive	NULL
sites	NULL
HS1	NULL
,	NULL
-2	NULL
,	NULL
-3	NULL
,	NULL
and	NULL
-4	NULL
in	NULL
the	NULL
locus	NULL
control	NULL
region	NULL
(	NULL
LCR	NULL
)	NULL
between	NULL
50	NULL
and	NULL
70	NULL
kilobases	NULL
(	NULL
kb	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
-globin	NULL
gene	NULL
.	NULL

HS2	NULL
at	NULL
-11	NULL
kb	NULL
5	NULL
'	NULL
of	NULL
the	NULL
embryonic	NULL
&	NULL
-	NULL
and	NULL
thus	NULL
at	NULL
-54	NULL
kb	NULL
5	NULL
'	NULL
of	NULL
the	NULL
p-globin	NULL
gene	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
possess	NULL
an	NULL
erythroid-specific	NULL
and	NULL
developmentally	NULL
stable	NULL
enhancer	NULL
function	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

It	NULL
is	NULL
capable	NULL
of	NULL
stimulating	NULL
the	NULL
transcription	NULL
of	NULL
embryonic	NULL
s-	NULL
,	NULL
fetal	NULL
y-	NULL
,	NULL
and	NULL
adult	NULL
B-globin	NULL
genes	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
7-10	NULL
)	NULL
.	NULL

In	NULL
y5B-thalassemia	NULL
,	NULL
the	NULL
deletion	NULL
of	NULL
HS2	NULL
and	NULL
more	NULL
upstream	NULL
DNA	NULL
is	NULL
associated	NULL
with	NULL
transcriptional	NULL
silencing	NULL
of	NULL
the	NULL
far	NULL
downstream	NULL
-globin	NULL
gene	NULL
(	NULL
11-13	NULL
)	NULL
and	NULL
possibly	NULL
of	NULL
the	NULL
whole	NULL
-like	NULL
globin	NULL
gene	NULL
domain	NULL
.	NULL

How	NULL
the	NULL
HS2	NULL
enhancer	NULL
cooperates	NULL
with	NULL
distant	NULL
globin	NULL
promoter	NULL
sequences	NULL
to	NULL
stimulate	NULL
the	NULL
s-	NULL
,	NULL
y-	NULL
,	NULL
and	NULL
-globin	NULL
genes	NULL
at	NULL
the	NULL
respective	NULL
developmental	NULL
stage	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

Looping	NULL
(	NULL
14	NULL
)	NULL
and	NULL
tracking	NULL
(	NULL
15	NULL
)	NULL
mechanisms	NULL
have	NULL
been	NULL
proposed	NULL
to	NULL
explain	NULL
how	NULL
a	NULL
distant	NULL
enhancer	NULL
may	NULL
communicate	NULL
with	NULL
the	NULL
promoter	NULL
of	NULL
a	NULL
cis-linked	NULL
gene	NULL
(	NULL
14	NULL
,	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
the	NULL
detection	NULL
of	NULL
HS2	NULL
enhancer	NULL
transcripts	NULL
in	NULL
erythroid	NULL
cells	NULL
suggests	NULL
that	NULL
the	NULL
tandem	NULL
Apl	NULL
sites	NULL
and	NULL
other	NULL
sequence	NULL
motifs	NULL
in	NULL
the	NULL
enhancer	NULL
may	NULL
provide	NULL
entry	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
associated	NULL
with	NULL
the	NULL
transcriptional	NULL
machinery	NULL
that	NULL
track	NULL
the	NULL
DNA	NULL
and	NULL
synthesize	NULL
long	NULL
strands	NULL
of	NULL
RNA	NULL
through	NULL
the	NULL
intervening	NULL
DNA	NULL
into	NULL
the	NULL
cis-linked	NULL
gene	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

$	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

11219	NULL
The	NULL
possible	NULL
biological	NULL
significance	NULL
of	NULL
such	NULL
long	NULL
transcripts	NULL
in	NULL
enhancer	NULL
function	NULL
will	NULL
be	NULL
discussed	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Construction	NULL
of	NULL
Recombinant	NULL
Constructs	NULL
.	NULL

HS2-sP-CAT	NULL
and	NULL
eP-CAT	NULL
have	NULL
been	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

5'-HS2-zP-CAT	NULL
was	NULL
made	NULL
by	NULL
triple	NULL
ligation	NULL
of	NULL
the	NULL
following	NULL
fragments	NULL
:	NULL
the	NULL
180-base-pair	NULL
(	NULL
bp	NULL
)	NULL
BamHI-BspHI	NULL
of	NULL
HS2	NULL
with	NULL
the	NULL
BspHI	NULL
end-blunted	NULL
,	NULL
the	NULL
202-bp	NULL
BamHI-HindIII	NULL
of	NULL
e-globin	NULL
promoter	NULL
(	NULL
5	NULL
)	NULL
with	NULL
the	NULL
BamHI	NULL
end-blunted	NULL
,	NULL
and	NULL
a	NULL
5.5-kb	NULL
Bgl	NULL
II-HindIll	NULL
vector	NULL
fragment	NULL
excised	NULL
from	NULL
pA10CAT2	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
3'-HS2-zP-CAT	NULL
was	NULL
made	NULL
by	NULL
splicing	NULL
the	NULL
520-bp	NULL
BspHI	NULL
(	NULL
blunted	NULL
)	NULL
-Stu	NULL
I	NULL
of	NULL
HS2	NULL
into	NULL
HS2-sp-CAT	NULL
that	NULL
had	NULL
been	NULL
digested	NULL
with	NULL
Sal	NULL
I	NULL
(	NULL
blunted	NULL
)	NULL
and	NULL
Stu	NULL
I	NULL
,	NULL
which	NULL
removed	NULL
all	NULL
HS2	NULL
but	NULL
the	NULL
40	NULL
bp	NULL
between	NULL
the	NULL
Stu	NULL
I	NULL
and	NULL
Bai	NULL
II	NULL
sites	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
.	NULL

Creation	NULL
of	NULL
K562	NULL
and	NULL
HL-60	NULL
Cell	NULL
Lines	NULL
and	NULL
Chloramphenicol	NULL
Acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
Assays	NULL
.	NULL

Each	NULL
recombinant	NULL
CAT	NULL
plasmid	NULL
at	NULL
10	NULL
ug	NULL
and	NULL
pcDneo	NULL
(	NULL
19	NULL
)	NULL
at	NULL
0.4	NULL
ug	NULL
were	NULL
introduced	NULL
into	NULL
10	NULL
``	NULL
K562	NULL
or	NULL
HL-60	NULL
cells	NULL
by	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
or	NULL
electroporation	NULL
as	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

G418	NULL
at	NULL
400	NULL
ug/ml	NULL
was	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
24	NULL
hr	NULL
after	NULL
glycerol	NULL
shock	NULL
.	NULL

Individual	NULL
pure	NULL
clones	NULL
were	NULL
picked	NULL
and	NULL
expanded	NULL
;	NULL
the	NULL
remaining	NULL
colonies	NULL
on	NULL
the	NULL
dish	NULL
were	NULL
expanded	NULL
for	NULL
pooled	NULL
clones	NULL
.	NULL

The	NULL
CAT	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Purification	NULL
of	NULL
RNA	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
(	NULL
20	NULL
)	NULL
from	NULL
2-4	NULL
x	NULL
10	NULL
``	NULL
freshly	NULL
harvested	NULL
cells	NULL
grown	NULL
for	NULL
48	NULL
hr	NULL
in	NULL
medium	NULL
with	NULL
20	NULL
4M	NULL
hemin	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
RNA	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
an	NULL
appropriate	NULL
buffer	NULL
and	NULL
digested	NULL
with	NULL
RNase-free	NULL
DNase	NULL
I	NULL
(	NULL
300	NULL
units/ml	NULL
)	NULL
(	NULL
from	NULL
Boehringer	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
and	NULL
then	NULL
with	NULL
proteinase	NULL
K	NULL
(	NULL
100	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
extracted	NULL
twice	NULL
with	NULL
phenol/chloroform	NULL
,	NULL
precipitated	NULL
in	NULL
ethanol	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

RNA	NULL
Protection	NULL
Assays	NULL
.	NULL

(	NULL
i	NULL
)	NULL
The	NULL
pGem-HS2-eP-CAT	NULL
construct	NULL
for	NULL
synthesizing	NULL
P1-P3	NULL
probes	NULL
:	NULL
The	NULL
template	NULL
DNA	NULL
excised	NULL
from	NULL
HS2-sP-CAT	NULL
by	NULL
double	NULL
digestion	NULL
with	NULL
Sal	NULL
I	NULL
,	NULL
cleaving	NULL
5	NULL
'	NULL
of	NULL
the	NULL
HS2	NULL
sequence	NULL
,	NULL
and	NULL
EcoRI	NULL
,	NULL
cleaving	NULL
at	NULL
base	NULL
271	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
,	NULL
was	NULL
spliced	NULL
into	NULL
pGem-3	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
between	NULL
the	NULL
Sal	NULL
I	NULL
and	NULL
EcoRI	NULL
sites	NULL
in	NULL
the	NULL
poly-linker	NULL
.	NULL

P1	NULL
probe	NULL
was	NULL
synthesized	NULL
by	NULL
T7	NULL
polymerase	NULL
from	NULL
Sal	NULL
T-linearized	NULL
template	NULL
plasmid	NULL
,	NULL
P3	NULL
probe	NULL
was	NULL
synthesized	NULL
by	NULL
Sp6	NULL
from	NULL
an	NULL
EcoRI-linearized	NULL
template	NULL
plasmid	NULL
,	NULL
and	NULL
P2	NULL
probe	NULL
was	NULL
synthesized	NULL
by	NULL
T7	NULL
polymerase	NULL
from	NULL
the	NULL
template	NULL
construct	NULL
linearized	NULL
with	NULL
BamHI	NULL
,	NULL
which	NULL
cleaves	NULL
between	NULL
HS2	NULL
and	NULL
the	NULL
e-globin	NULL
promoter	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
The	NULL
protection	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

RNA	NULL
probe	NULL
(	NULL
2-4	NULL
x	NULL
10°	NULL
cpm	NULL
)	NULL
and	NULL
RNA	NULL
(	NULL
30-50	NULL
ug	NULL
)	NULL
were	NULL
hybridized	NULL
at	NULL
53°C	NULL
for	NULL
16	NULL
hr	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
digested	NULL
for	NULL
30	NULL
min	NULL
at	NULL
25°C	NULL
(	NULL
or	NULL
30-37°C	NULL
)	NULL
with	NULL
RNase	NULL
at	NULL
25	NULL
(	NULL
or	NULL
35-40	NULL
)	NULL
ug/ml	NULL
and	NULL
RNase	NULL
TI	NULL
at	NULL
2	NULL
ug/ml	NULL
.	NULL

Hae	NULL
Ill-cut	NULL
$	NULL
X	NULL
DNA	NULL
or	NULL
interleukin	NULL
1	NULL
sequencing	NULL
ladders	NULL
served	NULL
as	NULL
size	NULL
markers	NULL
in	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Undigested	NULL
Abbreviations	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
HS	NULL
,	NULL
hypersensitive	NULL
site	NULL
;	NULL
LCR	NULL
,	NULL
locus	NULL
control	NULL
region	NULL
;	NULL
nt	NULL
,	NULL
nucleotide	NULL
(	NULL
s	NULL
)	NULL
.	NULL

To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

11220	NULL
-	NULL
Biochemistry	NULL
:	NULL
Tuan	NULL
et	NULL
al	NULL
.	NULL

probes	NULL
(	NULL
2000	NULL
cpm	NULL
)	NULL
were	NULL
also	NULL
loaded	NULL
into	NULL
individual	NULL
lanes	NULL
.	NULL

For	NULL
quantitative	NULL
analysis	NULL
,	NULL
the	NULL
bands	NULL
generated	NULL
by	NULL
the	NULL
CAT	NULL
mRNA	NULL
[	NULL
291	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
]	NULL
and	NULL
upstream	NULL
transcripts	NULL
of	NULL
the	NULL
endogenous	NULL
s-globin	NULL
gene	NULL
(	NULL
200	NULL
nt	NULL
)	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
and	NULL
radioactivity	NULL
was	NULL
measured	NULL
.	NULL

The	NULL
latter	NULL
served	NULL
as	NULL
the	NULL
internal	NULL
reference	NULL
for	NULL
calculating	NULL
relative	NULL
CAT	NULL
mRNA	NULL
levels	NULL
.	NULL

RESULTS	NULL
HS2	NULL
Enhancer	NULL
Activity	NULL
in	NULL
K562	NULL
and	NULL
HL-60	NULL
Cells	NULL
.	NULL

In	NULL
erythroid	NULL
K562	NULL
cells	NULL
,	NULL
the	NULL
HS2	NULL
enhancer	NULL
in	NULL
integrated	NULL
HS2-eP-CAT	NULL
plasmids	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
activated	NULL
synthesis	NULL
of	NULL
CAT	NULL
mRNA	NULL
and	NULL
CAT	NULL
enzyme	NULL
by	NULL
600-	NULL
to	NULL
3500-fold	NULL
over	NULL
those	NULL
produced	NULL
by	NULL
the	NULL
enhancerless	NULL
sP-CAT	NULL
plasmids	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
nonerythroid	NULL
HL-60	NULL
cells	NULL
,	NULL
the	NULL
HS2	NULL
enhancer	NULL
did	NULL
not	NULL
activate	NULL
the	NULL
synthesis	NULL
of	NULL
either	NULL
CAT	NULL
mRNA	NULL
or	NULL
CAT	NULL
enzyme	NULL
.	NULL

In	NULL
KS562	NULL
Cells	NULL
,	NULL
the	NULL
HS2	NULL
Enhancer	NULL
Directs	NULL
the	NULL
Synthesis	NULL
of	NULL
Long	NULL
Enhancer	NULL
Transcripts	NULL
into	NULL
the	NULL
CAT	NULL
Gene	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
sense	NULL
transcripts	NULL
of	NULL
the	NULL
integrated	NULL
HS2-ep-CAT	NULL
plasmid	NULL
,	NULL
two	NULL
antisense	NULL
RNA	NULL
probes	NULL
were	NULL
synthesized	NULL
:	NULL
a	NULL
full-length	NULL
Pi	NULL
probe	NULL
of	NULL
1300	NULL
nt	NULL
and	NULL
a	NULL
shorter	NULL
P2	NULL
probe	NULL
that	NULL
spanned	NULL
essentially	NULL
the	NULL
471	NULL
nt	NULL
at	NULL
the	NULL
5°	NULL
end	NULL
of	NULL
P1	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
.	NULL

Both	NULL
probes	NULL
share	NULL
common	NULL
5	NULL
'	NULL
ends	NULL
corresponding	NULL
to	NULL
base	NULL
271	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
antisense	NULL
transcripts	NULL
of	NULL
the	NULL
integrated	NULL
plasmid	NULL
,	NULL
a	NULL
sense	NULL
P3	NULL
probe	NULL
of	NULL
1300	NULL
nt	NULL
was	NULL
synthe-sized	NULL
.	NULL

Five	NULL
pure	NULL
clones	NULL
and	NULL
one	NULL
mixed	NULL
clone	NULL
of	NULL
HS2-ep-CAT-transformed	NULL
KS62	NULL
cells	NULL
,	NULL
containing	NULL
an	NULL
average	NULL
number	NULL
of	NULL
5-10	NULL
integrated	NULL
plasmids	NULL
per	NULL
cell	NULL
(	NULL
Southern	NULL
blots	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
were	NULL
studied	NULL
.	NULL

The	NULL
Pl-protected	NULL
bands	NULL
are	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

3a	NULL
and	NULL
analyzed	NULL
in	NULL
Fig	NULL
.	NULL

2b	NULL
.	NULL

In	NULL
each	NULL
of	NULL
the	NULL
HS2-containing	NULL
clones	NULL
,	NULL
the	NULL
CAT	NULL
mRNA	NULL
initiated	NULL
at	NULL
the	NULL
proper	NULL
cap	NULL
site	NULL
(	NULL
22	NULL
)	NULL
produced	NULL
a	NULL
prominent	NULL
protected	NULL
band	NULL
of	NULL
291	NULL
nt	NULL
(	NULL
Figs	NULL
.	NULL

2b	NULL
and	NULL
3a	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
enhancerless	NULL
sP-CAT	NULL
plasmid	NULL
integrated	NULL
at	NULL
an	NULL
average	NULL
copy	NULL
number	NULL
of	NULL
300	NULL
per	NULL
cell	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
produced	NULL
only	NULL
a	NULL
very	NULL
faint	NULL
band	NULL
of	NULL
291	NULL
nt	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
.	NULL

The	NULL
intense	NULL
band	NULL
of	NULL
200	NULL
nt	NULL
,	NULL
detected	NULL
in	NULL
all	NULL
the	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
,	NULL
was	NULL
produced	NULL
between	NULL
the	NULL
200	NULL
nt	NULL
of	NULL
s-globin	NULL
promoter	NULL
sequence	NULL
in	NULL
the	NULL
P1	NULL
probe	NULL
and	NULL
the	NULL
upstream	NULL
transcripts	NULL
of	NULL
the	NULL
endogenous	NULL
e-globin	NULL
gene	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
the	NULL
HS2-sP-CAT-transformed	NULL
clones	NULL
,	NULL
additional	NULL
bands	NULL
of	NULL
longer	NULL
lengths	NULL
were	NULL
detected	NULL
.	NULL

The	NULL
two	NULL
prominent	NULL
bands	NULL
of	NULL
435	NULL
and	NULL
425	NULL
nt	NULL
were	NULL
generated	NULL
by	NULL
upstream	NULL
transcripts	NULL
initiated	NULL
from	NULL
within	NULL
the	NULL
e-globin	NULL
promoter	NULL
.	NULL

The	NULL
471-nt	NULL
band	NULL
may	NULL
be	NULL
an	NULL
artifact	NULL
as	NULL
it	NULL
was	NULL
not	NULL
consistently	NULL
detected	NULL
in	NULL
all	NULL
the	NULL
HS2	NULL
clones	NULL
nor	NULL
in	NULL
the	NULL
same	NULL
pooled	NULL
clones	NULL
of	NULL
sP-CAT	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

The	NULL
bands	NULL
longer	NULL
than	NULL
471	NULL
nt	NULL
,	NULL
including	NULL
the	NULL
five	NULL
bands	NULL
of	NULL
1030-750	NULL
nt	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
gel	NULL
lanes	NULL
,	NULL
were	NULL
generated	NULL
by	NULL
long	NULL
transcripts	NULL
that	NULL
were	NULL
initiated	NULL
apparently	NULL
from	NULL
within	NULL
the	NULL
HS2	NULL
enhancer	NULL
and	NULL
extended	NULL
through	NULL
the	NULL
s-globin	NULL
promoter	NULL
into	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
.	NULL

As	NULL
most	NULL
of	NULL
the	NULL
long	NULL
enhancer	NULL
transcripts	NULL
extended	NULL
beyond	NULL
base	NULL
271	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
data	NULL
using	NULL
a	NULL
CAT	NULL
gene	NULL
probe	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
the	NULL
P1-protected	NULL
segments	NULL
of	NULL
the	NULL
long	NULL
transcripts	NULL
should	NULL
all	NULL
share	NULL
common	NULL
3	NULL
'	NULL
ends	NULL
at	NULL
base	NULL
271	NULL
of	NULL
the	NULL
HS2	NULL
5	NULL
'	NULL
;	NULL
3|	NULL
;	NULL
v	NULL
e	NULL
a	NULL
``	NULL
J	NULL
joe	NULL
.174	NULL
ns2	NULL
&	NULL
-o	NULL
mmm	NULL
0.74	NULL
-	NULL
0.2	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Recombinant	NULL
CAT	NULL
constructs	NULL
.	NULL

The	NULL
globin	NULL
gene	NULL
locus	NULL
upstream	NULL
of	NULL
the	NULL
s-globin	NULL
gene	NULL
(	NULL
solid	NULL
box	NULL
)	NULL
.	NULL

H	NULL
,	NULL
HindIII	NULL
;	NULL
Bg	NULL
,	NULL
BglII	NULL
;	NULL
Ba	NULL
,	NULL
BamHI	NULL
;	NULL
Pv	NULL
,	NULL
Pvu	NULL
IL	NULL
.	NULL

Vertical	NULL
arrow	NULL
,	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
HS2	NULL
(	NULL
1	NULL
)	NULL
;	NULL
ep	NULL
,	NULL
the	NULL
0.2-kb	NULL
s-globin	NULL
promoter	NULL
between	NULL
Ba	NULL
and	NULL
Pv	NULL
;	NULL
HS2	NULL
,	NULL
the	NULL
0.74-kb	NULL
DNA	NULL
between	NULL
H	NULL
and	NULL
Bg	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
Table	NULL
1	NULL
.	NULL

HS2	NULL
enhancer	NULL
activity	NULL
measured	NULL
by	NULL
CAT	NULL
enzymatic	NULL
and	NULL
RNA	NULL
protection	NULL
assays	NULL
Plasmids	NULL
,	NULL
Relative	NULL
CAT	NULL
Relative	NULL
Plamid	NULL
no	NULL
.	NULL

per	NULL
cell	NULL
_	NULL
enzymatic	NULL
activity	NULL
CAT	NULL
mRNA	NULL
K562	NULL
ep-CAT	NULL
300	NULL
1	NULL
1	NULL
HS2	NULL
2	NULL
3500	NULL
+	NULL
330	NULL
1020	NULL
+	NULL
360	NULL
(	NULL
HS2	NULL
)	NULL
3	NULL
2000	NULL
600	NULL
5'HS2	NULL
20	NULL
75	NULL
48	NULL
3HS2	NULL
6	NULL
367	NULL
40	NULL
HL-60	NULL
(	NULL
ep-CAT	NULL
)	NULL
20	NULL
1	NULL
0	NULL
(	NULL
HS2	NULL
)	NULL
4	NULL
1.2	NULL
0	NULL
Recombinant	NULL
CAT	NULL
plasmids	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
4a	NULL
)	NULL
were	NULL
stably	NULL
integrated	NULL
into	NULL
K562	NULL
or	NULL
HL-60	NULL
cells	NULL
.	NULL

Plasmids	NULL
in	NULL
parentheses	NULL
were	NULL
introduced	NULL
into	NULL
cells	NULL
by	NULL
electroporation	NULL
;	NULL
others	NULL
were	NULL
introduced	NULL
by	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
.	NULL

The	NULL
average	NULL
number	NULL
of	NULL
copies	NULL
per	NULL
cell	NULL
of	NULL
integrated	NULL
plasmids	NULL
in	NULL
pooled	NULL
clones	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
relative	NULL
CAT	NULL
enzymatic	NULL
activities	NULL
and	NULL
CAT	NULL
mRNA	NULL
levels	NULL
per	NULL
copy	NULL
of	NULL
integrated	NULL
plasmids	NULL
are	NULL
shown	NULL
;	NULL
respective	NULL
values	NULL
of	NULL
sp-CAT	NULL
were	NULL
used	NULL
as	NULL
the	NULL
standard	NULL
of	NULL
comparison	NULL
.	NULL

CAT	NULL
gene	NULL
after	NULL
RNase	NULL
digestion	NULL
.	NULL

By	NULL
using	NULL
this	NULL
common	NULL
3	NULL
'	NULL
end	NULL
as	NULL
reference	NULL
,	NULL
the	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
long	NULL
transcripts	NULL
mapped	NULL
a	NULL
CAP	NULL
r	NULL
’	NULL
5	NULL
'	NULL
r	NULL
’	NULL
3	NULL
'	NULL
Pape	NULL
[	NULL
__	NULL
HS2	NULL
I	NULL
eP	NULL
|	NULL
CAT	NULL
IPT7	NULL
33°C	NULL
735	NULL
'	NULL
200	NULL
|	NULL
271	NULL
``	NULL
J	NULL
20	NULL
pro	NULL
i	NULL
735	NULL
|	NULL
200	NULL
|	NULL
27	NULL
5	NULL
!	NULL

200	NULL
|	NULL
271	NULL
p2	NULL
«	NULL
--	NULL
--	NULL
-	NULL
&	NULL
.	NULL

3	NULL
P3	NULL
__	NULL
[	NULL
==	NULL
4	NULL
b	NULL
200	NULL
b	NULL
.it	NULL
5°	NULL
eRNA	NULL
I	NULL
$	NULL
0	NULL
CAT	NULL
m	NULL
RNA	NULL
L	NULL
meg—Hg	NULL
;	NULL
LC	NULL
810nt	NULL
47W	NULL
87O0nt	NULL
6M	NULL
940nt	NULL
seo	NULL
:	NULL
25	NULL
)	NULL
=P	NULL
-	NULL
1O3Ont	NULL
C	NULL
200	NULL
5°	NULL
eRNA	NULL
291	NULL
W	NULL
CAT	NULL
m	NULL
RNA	NULL
47	NULL
|	NULL
R	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Analysis	NULL
of	NULL
enhancer	NULL
transcripts	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Template	NULL
construct	NULL
for	NULL
synthesis	NULL
of	NULL
RNA	NULL
probes	NULL
.	NULL

Thick	NULL
or	NULL
thin	NULL
horizontal	NULL
lines	NULL
,	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
strands	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
DNA	NULL
and	NULL
RNA	NULL
;	NULL
numbers	NULL
,	NULL
sizes	NULL
in	NULL
bp	NULL
or	NULL
nt	NULL
of	NULL
the	NULL
DNA	NULL
or	NULL
RNA	NULL
fragments	NULL
;	NULL
CAP	NULL
,	NULL
the	NULL
cap	NULL
site	NULL
of	NULL
CAT	NULL
mRNA	NULL
20	NULL
bp	NULL
into	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
e	NULL
promoter	NULL
;	NULL
small	NULL
angled	NULL
arrows	NULL
above	NULL
and	NULL
below	NULL
the	NULL
S	NULL
$	NULL
p6	NULL
and	NULL
T7	NULL
promoters	NULL
,	NULL
the	NULL
direction	NULL
of	NULL
synthesis	NULL
of	NULL
the	NULL
RNA	NULL
probes	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Analysis	NULL
of	NULL
protected	NULL
sense	NULL
transcripts	NULL
.	NULL

Horizontal	NULL
arrows	NULL
,	NULL
probe-protected	NULL
sense	NULL
transcripts	NULL
generated	NULL
from	NULL
5	NULL
'	NULL
sRNA	NULL
,	NULL
the	NULL
upstream	NULL
transcripts	NULL
of	NULL
the	NULL
endogenous	NULL
s-globin	NULL
gene	NULL
,	NULL
CAT	NULL
mRNA	NULL
,	NULL
and	NULL
long	NULL
enhancer	NULL
transcripts	NULL
;	NULL
numbers	NULL
to	NULL
the	NULL
right	NULL
,	NULL
average	NULL
lengths	NULL
in	NULL
nt	NULL
of	NULL
the	NULL
protected	NULL
enhancer	NULL
transcripts	NULL
determined	NULL
from	NULL
three	NULL
to	NULL
six	NULL
separate	NULL
experiments	NULL
;	NULL
short	NULL
vertical	NULL
bars	NULL
,	NULL
junction	NULL
between	NULL
the	NULL
enhancer	NULL
and	NULL
the	NULL
promoter	NULL
that	NULL
are	NULL
vertically	NULL
aligned	NULL
with	NULL
those	NULL
in	NULL
a	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Analysis	NULL
of	NULL
P2-protected	NULL
sense	NULL
transcripts	NULL
.	NULL

Biochemistry	NULL
:	NULL
Tuan	NULL
et	NULL
al	NULL
.	NULL

%	NULL
%	NULL
:	NULL
o	NULL
-	NULL
|	NULL
M6	NULL
Q	NULL
g	NULL
*	NULL
201	NULL
-	NULL
M	NULL
«	NULL
k	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
-	NULL
11221	NULL
34	NULL
6	NULL
,	NULL
@	NULL
l	NULL
Lal	NULL
®	NULL
,	NULL
w	NULL
%	NULL
[	NULL
®	NULL
me	NULL
a	NULL
..	NULL
%	NULL
@	NULL
#	NULL
«	NULL
te	NULL
@	NULL
&	NULL
e	NULL
bs	NULL
C	NULL
-	NULL
@	NULL
PB	NULL
#	NULL
FiG	NULL
.	NULL

3	NULL
.	NULL

RNA	NULL
protection	NULL
assays	NULL
of	NULL
sense	NULL
and	NULL
antisense	NULL
CAT	NULL
RNAs	NULL
from	NULL
K562	NULL
and	NULL
HL-60	NULL
cells	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Pl-protected	NULL
sense	NULL
transcripts	NULL
in	NULL
K562	NULL
RNAs	NULL
.	NULL

Lanes	NULL
:	NULL
eP	NULL
,	NULL
RNA	NULL
isolated	NULL
from	NULL
pooled	NULL
clones	NULL
transformed	NULL
by	NULL
sp-CAT	NULL
;	NULL
HS2	NULL
,	NULL
1-5	NULL
,	NULL
five	NULL
pure	NULL
clones	NULL
transformed	NULL
by	NULL
HS2-sp-CAT	NULL
;	NULL
Mix	NULL
,	NULL
a	NULL
mixed	NULL
population	NULL
of	NULL
10	NULL
pure	NULL
clones	NULL
transformed	NULL
by	NULL
HS2-sP-CAT	NULL
;	NULL
P1	NULL
,	NULL
undigested	NULL
P1	NULL
probe	NULL
.	NULL

Numbers	NULL
mark	NULL
sizes	NULL
in	NULL
nt	NULL
of	NULL
protected	NULL
bands	NULL
.	NULL

Lane	NULL
M	NULL
contains	NULL
Hae	NULL
III-digested	NULL
$	NULL
X	NULL
size	NULL
markers	NULL
.	NULL

Exposure	NULL
time	NULL
,	NULL
12	NULL
hr	NULL
.	NULL

(	NULL
b	NULL
)	NULL
P2-protected	NULL
sense	NULL
transcripts	NULL
in	NULL
K562	NULL
RNAs	NULL
.	NULL

Lanes	NULL
:	NULL
sP	NULL
,	NULL
a	NULL
different	NULL
preparation	NULL
of	NULL
RNA	NULL
from	NULL
the	NULL
same	NULL
pooled	NULL
clones	NULL
of	NULL
sP-CAT	NULL
used	NULL
in	NULL
lane	NULL
sP	NULL
of	NULL
a	NULL
;	NULL
Yeast	NULL
,	NULL
yeast	NULL
t-RNA	NULL
.	NULL

P2	NULL
,	NULL
undigested	NULL
P2	NULL
probe	NULL
;	NULL
HS2	NULL
,	NULL
RNA	NULL
from	NULL
pooled	NULL
clones	NULL
transformed	NULL
by	NULL
HS2-sP-CAT	NULL
;	NULL
M	NULL
,	NULL
as	NULL
in	NULL
a	NULL
.	NULL

Exposure	NULL
time	NULL
,	NULL
36	NULL
hr	NULL
.	NULL

(	NULL
c	NULL
)	NULL
P3-protected	NULL
anti-sense	NULL
transcripts	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

The	NULL
top	NULL
band	NULL
in	NULL
lane	NULL
P3	NULL
is	NULL
the	NULL
full-length	NULL
P3	NULL
probe	NULL
;	NULL
smaller	NULL
bands	NULL
are	NULL
prematurely	NULL
terminated	NULL
P3	NULL
probe	NULL
.	NULL

Lanes	NULL
:	NULL
HS2	NULL
,	NULL
yeast	NULL
,	NULL
and	NULL
M	NULL
,	NULL
as	NULL
in	NULL
b	NULL
.	NULL

Exposure	NULL
times	NULL
:	NULL
HS2	NULL
lane	NULL
,	NULL
52	NULL
hr	NULL
;	NULL
other	NULL
lanes	NULL
,	NULL
28	NULL
hr	NULL
.	NULL

(	NULL
d	NULL
)	NULL
Pl-protected	NULL
transcripts	NULL
in	NULL
HL-60	NULL
cells	NULL
.	NULL

Lanes	NULL
:	NULL
zP	NULL
and	NULL
HS2	NULL
,	NULL
RNA	NULL
from	NULL
pooled	NULL
clones	NULL
of	NULL
sP-CAT-and	NULL
HS2-eP-CAT-transformed	NULL
HL-60	NULL
cells	NULL
,	NULL
respectively	NULL
;	NULL
P1	NULL
and	NULL
M	NULL
,	NULL
as	NULL
in	NULL
a	NULL
.	NULL

Exposure	NULL
time	NULL
,	NULL
60	NULL
hr	NULL
.	NULL

within	NULL
the	NULL
HS2	NULL
enhancer	NULL
at	NULL
sites	NULL
560	NULL
,	NULL
470	NULL
,	NULL
400	NULL
,	NULL
340	NULL
,	NULL
and	NULL
280	NULL
nt	NULL
from	NULL
the	NULL
3	NULL
'	NULL
border	NULL
of	NULL
the	NULL
HS2	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

26	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
P1	NULL
probe	NULL
was	NULL
labeled	NULL
homogenously	NULL
throughout	NULL
its	NULL
length	NULL
and	NULL
not	NULL
merely	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
,	NULL
the	NULL
Pl-protected	NULL
bands	NULL
of	NULL
1030-750	NULL
nt	NULL
might	NULL
also	NULL
be	NULL
generated	NULL
from	NULL
transcripts	NULL
initiated	NULL
from	NULL
sites	NULL
more	NULL
upstream	NULL
of	NULL
the	NULL
above	NULL
mapped	NULL
sites	NULL
and	NULL
terminated	NULL
prematurely	NULL
upstream	NULL
of	NULL
base	NULL
271	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
the	NULL
shorter	NULL
P2	NULL
probe	NULL
spanning	NULL
only	NULL
the	NULL
extreme	NULL
5	NULL
'	NULL
471	NULL
nt	NULL
of	NULL
P1	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
would	NULL
hybridize	NULL
to	NULL
those	NULL
prematurely	NULL
terminated	NULL
transcripts	NULL
with	NULL
heterogenous	NULL
3	NULL
'	NULL
ends	NULL
and	NULL
generate	NULL
a	NULL
new	NULL
ladder	NULL
of	NULL
protected	NULL
bands	NULL
shorter	NULL
than	NULL
471	NULL
nt	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
if	NULL
the	NULL
long	NULL
transcripts	NULL
were	NULL
initiated	NULL
from	NULL
the	NULL
various	NULL
mapped	NULL
sites	NULL
in	NULL
the	NULL
enhancer	NULL
and	NULL
extended	NULL
beyond	NULL
base	NULL
271	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
,	NULL
the	NULL
P2	NULL
probe	NULL
would	NULL
hybridize	NULL
to	NULL
the	NULL
3	NULL
'	NULL
part	NULL
of	NULL
this	NULL
array	NULL
of	NULL
long	NULL
transcripts	NULL
and	NULL
produce	NULL
a	NULL
single	NULL
prominent	NULL
band	NULL
of	NULL
471	NULL
nt	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
a-c	NULL
for	NULL
alignment	NULL
of	NULL
P2	NULL
probe	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
enhancer	NULL
transcripts	NULL
)	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
a	NULL
prominent	NULL
P2-protected	NULL
band	NULL
of	NULL
471	NULL
nt	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
provides	NULL
support	NULL
for	NULL
the	NULL
latter	NULL
analysis	NULL
.	NULL

The	NULL
prominent	NULL
ladder	NULL
of	NULL
bands	NULL
of	NULL
425	NULL
,	NULL
291	NULL
,	NULL
and	NULL
200	NULL
nt	NULL
was	NULL
detected	NULL
by	NULL
both	NULL
the	NULL
short	NULL
P2	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
and	NULL
the	NULL
long	NULL
P1	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
.	NULL

They	NULL
were	NULL
produced	NULL
not	NULL
by	NULL
long	NULL
enhancer	NULL
transcripts	NULL
but	NULL
,	NULL
respectively	NULL
,	NULL
by	NULL
shorter	NULL
transcripts	NULL
initiated	NULL
in	NULL
the	NULL
e-globin	NULL
promoter	NULL
,	NULL
CAT	NULL
mRNA	NULL
,	NULL
and	NULL
upstream	NULL
transcripts	NULL
of	NULL
the	NULL
endogenous	NULL
e-globin	NULL
gene	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
many	NULL
faint	NULL
bands	NULL
present	NULL
in	NULL
the	NULL
HS2	NULL
lanes	NULL
of	NULL
Fig	NULL
.	NULL

3	NULL
a	NULL
and	NULL
b	NULL
were	NULL
not	NULL
derived	NULL
from	NULL
prematurely	NULL
terminated	NULL
upstream	NULL
transcripts	NULL
.	NULL

The	NULL
electroporation	NULL
method	NULL
was	NULL
also	NULL
used	NULL
to	NULL
introduce	NULL
recombinant	NULL
plasmids	NULL
into	NULL
K562	NULL
cells	NULL
.	NULL

The	NULL
patterns	NULL
of	NULL
P1-protected	NULL
bands	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3a	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
minimize	NULL
clonal	NULL
variations	NULL
in	NULL
HS2	NULL
enhancer	NULL
transcription	NULL
and	NULL
function	NULL
caused	NULL
by	NULL
a	NULL
different	NULL
assortment	NULL
of	NULL
host	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
clonal	NULL
integration	NULL
sites	NULL
,	NULL
the	NULL
current	NULL
study	NULL
except	NULL
for	NULL
data	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

3a	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
pooled	NULL
clones	NULL
containing	NULL
transfecting	NULL
plasmids	NULL
randomly	NULL
integrated	NULL
into	NULL
multiple	NULL
host	NULL
chromoso-mal	NULL
sites	NULL
.	NULL

The	NULL
HS2	NULL
enhancer	NULL
in	NULL
pooled	NULL
clones	NULL
of	NULL
HS2-sP-CAT-transformed	NULL
K562	NULL
cells	NULL
did	NULL
not	NULL
direct	NULL
the	NULL
synthesis	NULL
of	NULL
detectable	NULL
levels	NULL
of	NULL
antisense	NULL
transcripts	NULL
,	NULL
as	NULL
the	NULL
sense	NULL
P3	NULL
probe	NULL
did	NULL
not	NULL
produce	NULL
clearly	NULL
discernible	NULL
bands	NULL
(	NULL
Fig	NULL
.	NULL

3¢c	NULL
)	NULL
.	NULL

In	NULL
the	NULL
nonerythroid	NULL
HL-60	NULL
cells	NULL
,	NULL
the	NULL
HS2-eP-CAT	NULL
plasmid	NULL
integrated	NULL
at	NULL
an	NULL
average	NULL
copy	NULL
number	NULL
of	NULL
4-20	NULL
per	NULL
cell	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
generated	NULL
neither	NULL
the	NULL
1030-	NULL
to	NULL
750-nt	NULL
bands	NULL
produced	NULL
by	NULL
the	NULL
long	NULL
enhancer	NULL
transcripts	NULL
nor	NULL
the	NULL
291-nt	NULL
band	NULL
produced	NULL
by	NULL
the	NULL
CAT	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

3d	NULL
)	NULL
.	NULL

Tandem	NULL
Apl	NULL
Sites	NULL
in	NULL
HS2	NULL
Enhancer	NULL
Transcription	NULL
and	NULL
Function	NULL
.	NULL

Within	NULL
the	NULL
HS2	NULL
enhancer	NULL
,	NULL
the	NULL
26-bp	NULL
sequence	NULL
TGCTGAGTCATGATGAGTCATGCTGA	NULL
encompassing	NULL
two	NULL
tandem	NULL
Apl	NULL
sites	NULL
(	NULL
underlined	NULL
)	NULL
(	NULL
24	NULL
)	NULL
is	NULL
located	NULL
at	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
HS2	NULL
enhancer	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
enhancer	NULL
function	NULL
(	NULL
R.	NULL
Cavailesco	NULL
and	NULL
D.T	NULL
.	NULL

,	NULL
uripublished	NULL
observation	NULL
)	NULL
(	NULL
10	NULL
,	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Cleaving	NULL
the	NULL
735-bp	NULL
HS2	NULL
enhancer	NULL
between	NULL
the	NULL
two	NULL
tandem	NULL
Apl	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
caused	NULL
a	NULL
precipitous	NULL
drop	NULL
in	NULL
enhancer	NULL
transcription	NULL
and	NULL
function	NULL
.	NULL

The	NULL
5'-HS2-	NULL
and	NULL
the	NULL
3'-HS2-sP-CAT	NULL
plasmids	NULL
,	NULL
integrated	NULL
at	NULL
average	NULL
copy	NULL
numbers	NULL
3-10	NULL
times	NULL
that	NULL
of	NULL
the	NULL
parental	NULL
HS2	NULL
plasmids	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
produced	NULL
very	NULL
faint	NULL
bands	NULL
of	NULL
291	NULL
nt	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
and	NULL
accordingly	NULL
an	NULL
amount	NULL
of	NULL
CAT	NULL
mRNA	NULL
=20-fold	NULL
lower	NULL
than	NULL
the	NULL
parental	NULL
plasmid	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
,	NULL
the	NULL
CAT	NULL
enzymatic	NULL
activities	NULL
were	NULL
10-	NULL
to	NULL
50-fold	NULL
lower	NULL
(	NULL
Fig	NULL
.	NULL

4¢	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Associated	NULL
with	NULL
the	NULL
drastic	NULL
drop	NULL
in	NULL
enhancer	NULL
activity	NULL
,	NULL
the	NULL
3'-HS2	NULL
plasmid	NULL
produced	NULL
none	NULL
of	NULL
the	NULL
major	NULL
Pl-protected	NULL
bands	NULL
of	NULL
1030-750	NULL
nt	NULL
that	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
parental	NULL
HS2	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
,	NULL
even	NULL
though	NULL
the	NULL
560-bp	NULL
3	NULL
'	NULL
subfrag-ment	NULL
contains	NULL
all	NULL
the	NULL
potential	NULL
transcriptional	NULL
initiation	NULL
sites	NULL
for	NULL
these	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

The	NULL
prominent	NULL
new	NULL
band	NULL
of	NULL
520	NULL
nt	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
was	NULL
apparently	NULL
generated	NULL
by	NULL
an	NULL
enhancer	NULL
transcript	NULL
initiated	NULL
at	NULL
a	NULL
new	NULL
site	NULL
50	NULL
nt	NULL
upstream	NULL
of	NULL
the	NULL
Bel	NULL
II	NULL
site	NULL
11222	NULL
-	NULL
Biochemistry	NULL
:	NULL
Tuan	NULL
et	NULL
al	NULL
.	NULL

a	NULL
560	NULL
280	NULL
(	NULL
E	NULL
i	NULL
Pp	NULL
___	NULL
BSp___735	NULL
|_	NULL
eP	NULL
|	NULL
CAT	NULL
HS2	NULL
-	NULL
eP	NULL
-	NULL
CAT	NULL
;	NULL
200	NULL
,	NULL
27	NULL
!	NULL

PI	NULL
probe	NULL
(	NULL
ES	NULL
|	NULL
|	NULL
_eP	NULL
|	NULL
_	NULL
CAT	NULL
5	NULL
'	NULL
HS2-	NULL
eP-	NULL
CAT	NULL
160	NULL
,	NULL
Lid	NULL
PI	NULL
-	NULL
protected	NULL
RNA	NULL
560	NULL
eP	NULL
CAT	NULL
3'HS2-€EP-CAT	NULL
.	NULL

Pi-	NULL
protected	NULL
RNA	NULL
OQ	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Contiguity	NULL
of	NULL
tandem	NULL
Ap	NULL
!	NULL

sites	NULL
in	NULL
enhancer	NULL
transcription	NULL
and	NULL
function	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Transcription	NULL
of	NULL
recombinant	NULL
plasmids	NULL
containing	NULL
the	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
split	NULL
enhancer	NULL
.	NULL

The	NULL
parental	NULL
HS2-sP-CAT	NULL
plasmid	NULL
is	NULL
shown	NULL
at	NULL
the	NULL
top	NULL
.	NULL

Double	NULL
solid	NULL
boxes	NULL
,	NULL
the	NULL
two	NULL
tandem	NULL
Apl	NULL
sites	NULL
;	NULL
Bsp	NULL
,	NULL
BspHI	NULL
site	NULL
;	NULL
5'-HS2-ep-CAT	NULL
or	NULL
3'-HS2-eP-CAT	NULL
,	NULL
the	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
split	NULL
enhancer	NULL
containing	NULL
the	NULL
single	NULL
Ap	NULL
!	NULL

site	NULL
(	NULL
solid	NULL
box	NULL
)	NULL
linked	NULL
to	NULL
eP	NULL
and	NULL
the	NULL
CAT	NULL
gene	NULL
;	NULL
bent	NULL
line	NULL
in	NULL
5'-HS2-sP-CAT	NULL
,	NULL
absence	NULL
of	NULL
the	NULL
560-nt	NULL
3	NULL
'	NULL
sequence	NULL
;	NULL
heavy	NULL
horizontal	NULL
arrows	NULL
or	NULL
lines	NULL
,	NULL
Pl-protected	NULL
transcripts	NULL
from	NULL
the	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
split	NULL
enhancer	NULL
;	NULL
numbers	NULL
,	NULL
sizes	NULL
in	NULL
bp	NULL
or	NULL
nt	NULL
;	NULL
angled	NULL
arrows	NULL
,	NULL
apparent	NULL
initiation	NULL
sites	NULL
of	NULL
enhancer	NULL
transcripts	NULL
;	NULL
numbers	NULL
above	NULL
the	NULL
arrows	NULL
,	NULL
locations	NULL
of	NULL
the	NULL
initiation	NULL
sites	NULL
relative	NULL
to	NULL
the	NULL
Bg	NULL
site	NULL
at	NULL
the	NULL
3	NULL
'	NULL
border	NULL
of	NULL
HS2	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Pli-protected	NULL
transcripts	NULL
.	NULL

Lanes	NULL
:	NULL
5'-HS2	NULL
,	NULL
3'-HS2	NULL
,	NULL
and	NULL
HS2	NULL
,	NULL
RNA	NULL
isolated	NULL
from	NULL
5'-HS2-eP-CAT-	NULL
,	NULL
3'-HS2-zP-CAT-	NULL
,	NULL
and	NULL
the	NULL
parental	NULL
HS2-sP-CAT-transformed	NULL
K562	NULL
cells	NULL
;	NULL
0	NULL
,	NULL
RNA	NULL
from	NULL
nontransfected	NULL
K562	NULL
cells	NULL
;	NULL
M	NULL
,	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3b	NULL
;	NULL
Pl	NULL
and	NULL
yeast	NULL
,	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
a	NULL
and	NULL
b	NULL
.	NULL

Exposure	NULL
times	NULL
:	NULL
HS2	NULL
and	NULL
0	NULL
,	NULL
11	NULL
hr	NULL
;	NULL
other	NULL
lanes	NULL
,	NULL
20	NULL
hr	NULL
.	NULL

(	NULL
c	NULL
)	NULL
CAT	NULL
assays	NULL
for	NULL
HS2	NULL
,	NULL
5'-HS2	NULL
,	NULL
and	NULL
3'-HS2	NULL
.	NULL

at	NULL
the	NULL
3	NULL
'	NULL
border	NULL
of	NULL
HS2	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

The	NULL
690-nt	NULL
band	NULL
,	NULL
produced	NULL
by	NULL
both	NULL
the	NULL
5'-	NULL
and	NULL
3'-HS2	NULL
plasmids	NULL
and	NULL
very	NULL
faintly	NULL
by	NULL
yeast	NULL
RNA	NULL
but	NULL
not	NULL
reproducibly	NULL
by	NULL
the	NULL
parental	NULL
HS2	NULL
plasmid	NULL
(	NULL
Figs	NULL
.	NULL

3a	NULL
and	NULL
4b	NULL
)	NULL
might	NULL
be	NULL
generated	NULL
in	NULL
part	NULL
by	NULL
undigested	NULL
probe	NULL
.	NULL

In	NULL
both	NULL
the	NULL
parental	NULL
and	NULL
the	NULL
5'-HS2	NULL
plasmids	NULL
,	NULL
an	NULL
apparent	NULL
transcriptional	NULL
initiation	NULL
site	NULL
is	NULL
located	NULL
20	NULL
nt	NULL
downstream	NULL
of	NULL
the	NULL
Hind1III	NULL
site	NULL
at	NULL
the	NULL
5	NULL
'	NULL
border	NULL
of	NULL
HS2	NULL
.	NULL

In	NULL
the	NULL
parental	NULL
HS2	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
plasmid	NULL
,	NULL
this	NULL
transcript	NULL
produced	NULL
a	NULL
protected	NULL
band	NULL
of	NULL
1190	NULL
nt	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
;	NULL
in	NULL
the	NULL
5'-HS2	NULL
plasmid	NULL
,	NULL
two	NULL
protected	NULL
bands	NULL
of	NULL
471	NULL
nt	NULL
and	NULL
160	NULL
nt	NULL
were	NULL
produced	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
erythroid-specific	NULL
HS2	NULL
enhancer	NULL
,	NULL
stably	NULL
integrated	NULL
into	NULL
K562	NULL
cells	NULL
,	NULL
activates	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
cis-linked	NULL
CAT	NULL
gene	NULL
and	NULL
directs	NULL
the	NULL
synthesis	NULL
of	NULL
long	NULL
transcripts	NULL
that	NULL
are	NULL
elongated	NULL
through	NULL
the	NULL
intervening	NULL
DNA	NULL
into	NULL
the	NULL
cis-linked	NULL
gene	NULL
(	NULL
Figs	NULL
.	NULL

2b	NULL
and	NULL
3a	NULL
)	NULL
.	NULL

In	NULL
nonerythroid	NULL
HL-60	NULL
cells	NULL
,	NULL
the	NULL
long	NULL
enhancer	NULL
transcripts	NULL
were	NULL
not	NULL
detectable	NULL
and	NULL
the	NULL
CAT	NULL
gene	NULL
was	NULL
not	NULL
transcribed	NULL
(	NULL
Fig	NULL
.	NULL

30	NULL
)	NULL
.	NULL

The	NULL
long	NULL
enhancer	NULL
transcripts	NULL
appear	NULL
to	NULL
be	NULL
RNA	NULL
initiated	NULL
from	NULL
within	NULL
the	NULL
HS2	NULL
enhancer	NULL
rather	NULL
than	NULL
degradation	NULL
products	NULL
of	NULL
read-through	NULL
transcripts	NULL
initiated	NULL
from	NULL
within	NULL
the	NULL
tandemly	NULL
integrated	NULL
neighboring	NULL
plasmids	NULL
.	NULL

Individually	NULL
integrated	NULL
HS2-sP-CAT	NULL
plasmids	NULL
,	NULL
introduced	NULL
into	NULL
K562	NULL
cells	NULL
by	NULL
electroporation	NULL
,	NULL
produced	NULL
the	NULL
same	NULL
pattern	NULL
of	NULL
protected	NULL
bands	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
thus	NULL
the	NULL
same	NULL
long	NULL
enhancer	NULL
transcripts	NULL
as	NULL
the	NULL
tandemly	NULL
integrated	NULL
plasmids	NULL
introduced	NULL
by	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
.	NULL

The	NULL
integrity	NULL
of	NULL
the	NULL
tandem	NULL
API	NULL
sites	NULL
appears	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
enhancer	NULL
transcription	NULL
and	NULL
function	NULL
.	NULL

Splitting	NULL
the	NULL
enhancer	NULL
between	NULL
the	NULL
API	NULL
sites	NULL
results	NULL
in	NULL
disappearance	NULL
of	NULL
the	NULL
multiple	NULL
enhancer-initiated	NULL
long	NULL
transcripts	NULL
and	NULL
loss	NULL
of	NULL
enhancer	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
tandem	NULL
API	NULL
sites	NULL
may	NULL
drive	NULL
enhancer	NULL
function	NULL
by	NULL
communicating	NULL
with	NULL
the	NULL
far	NULL
downstream	NULL
promoter	NULL
through	NULL
synthesis	NULL
of	NULL
long	NULL
enhancer	NULL
transcripts	NULL
by	NULL
a	NULL
tracking	NULL
and	NULL
transcription	NULL
mechanism	NULL
.	NULL

The	NULL
tandem	NULL
Ap1	NULL
sites	NULL
bind	NULL
to	NULL
both	NULL
ubiquitous	NULL
Apl	NULL
factors	NULL
(	NULL
24	NULL
)	NULL
and	NULL
erythroid-specific	NULL
transcription	NULL
factor	NULL
NFE-2	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
Apl	NULL
site	NULL
also	NULL
shares	NULL
homology	NULL
with	NULL
the	NULL
binding	NULL
motifs	NULL
of	NULL
the	NULL
yeast	NULL
transcription	NULL
factor	NULL
GCN4	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
GCN4	NULL
binding	NULL
motifs	NULL
possess	NULL
TATA	NULL
box	NULL
function	NULL
and	NULL
are	NULL
capable	NULL
of	NULL
initiating	NULL
the	NULL
transcription	NULL
of	NULL
mRNA	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
Apl	NULL
sites	NULL
in	NULL
the	NULL
HS2	NULL
enhancer	NULL
may	NULL
thus	NULL
also	NULL
bind	NULL
to	NULL
mammalian	NULL
transcription	NULL
factors	NULL
similar	NULL
to	NULL
GCN4	NULL
and	NULL
initiate	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
long	NULL
enhancer	NULL
transcripts	NULL
.	NULL

One	NULL
possible	NULL
functional	NULL
role	NULL
of	NULL
the	NULL
gene-tropic	NULL
long	NULL
enhancer	NULL
transcripts	NULL
may	NULL
be	NULL
to	NULL
open	NULL
up	NULL
the	NULL
chromatin	NULL
structure	NULL
of	NULL
a	NULL
cis-linked	NULL
gene	NULL
domain	NULL
.	NULL

The	NULL
B-like	NULL
globin	NULL
gene	NULL
domain	NULL
of	NULL
erythroid	NULL
cells	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
possess	NULL
overall	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
and	NULL
exists	NULL
in	NULL
an	NULL
open	NULL
and	NULL
accessible	NULL
chromatin	NULL
structure	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
long	NULL
enhancer	NULL
transcripts	NULL
in	NULL
the	NULL
present	NULL
study	NULL
suggests	NULL
that	NULL
the	NULL
HS2	NULL
enhancer	NULL
in	NULL
the	NULL
LCR	NULL
may	NULL
unravel	NULL
and	NULL
open	NULL
up	NULL
the	NULL
chromatin	NULL
structure	NULL
of	NULL
the	NULL
-like	NULL
globin	NULL
gene	NULL
domain	NULL
by	NULL
directing	NULL
synthesis	NULL
of	NULL
long	NULL
strands	NULL
of	NULL
RNA	NULL
through	NULL
the	NULL
DNA	NULL
duplex	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
intervening	NULL
DNA	NULL
,	NULL
and	NULL
B-like	NULL
globin	NULL
genes	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
functional	NULL
role	NULL
of	NULL
the	NULL
HS2	NULL
enhancer	NULL
,	NULL
the	NULL
endogenous	NULL
HS2	NULL
sequence	NULL
of	NULL
K562	NULL
cells	NULL
has	NULL
been	NULL
found	NULL
to	NULL
be	NULL
transcribed	NULL
in	NULL
low	NULL
abundance	NULL
and	NULL
also	NULL
in	NULL
a	NULL
direction	NULL
toward	NULL
the	NULL
-like	NULL
globin	NULL
genes	NULL
(	NULL
RNA-PCR	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
deletion	NULL
of	NULL
HS2	NULL
and	NULL
more	NULL
upstream	NULL
DNA	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
cause	NULL
the	NULL
chromatin	NULL
structure	NULL
of	NULL
the	NULL
whole	NULL
B-like	NULL
globin	NULL
gene	NULL
domain	NULL
to	NULL
revert	NULL
to	NULL
a	NULL
closed	NULL
form	NULL
and	NULL
the	NULL
far	NULL
downstream	NULL
-globin	NULL
gene	NULL
to	NULL
be	NULL
transcriptionally	NULL
inaccessible	NULL
and	NULL
inactive	NULL
(	NULL
11-13	NULL
,	NULL
32	NULL
)	NULL
.	NULL

A	NULL
second	NULL
possible	NULL
function	NULL
of	NULL
the	NULL
enhancer	NULL
transcripts	NULL
may	NULL
be	NULL
to	NULL
deliver	NULL
enhancer	NULL
binding	NULL
proteins	NULL
to	NULL
the	NULL
promoter	NULL
where	NULL
these	NULL
proteins	NULL
may	NULL
interact	NULL
with	NULL
promoter	NULL
binding	NULL
proteins	NULL
to	NULL
stimulate	NULL
transcription	NULL
of	NULL
mRNA	NULL
at	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

Thus	NULL
,	NULL
when	NULL
synthesis	NULL
of	NULL
the	NULL
long	NULL
enhancer	NULL
transcripts	NULL
is	NULL
blocked	NULL
,	NULL
cap	NULL
transcription	NULL
of	NULL
mRNA	NULL
is	NULL
suppressed	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

As	NULL
synthesis	NULL
of	NULL
enhancer	NULL
transcripts	NULL
initiated	NULL
from	NULL
the	NULL
split	NULL
enhancers	NULL
outside	NULL
of	NULL
the	NULL
region	NULL
between	NULL
bases	NULL
560	NULL
and	NULL
280	NULL
in	NULL
HS2	NULL
does	NULL
not	NULL
appreciably	NULL
activate	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
only	NULL
the	NULL
initiation	NULL
complexes	NULL
containing	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
sequence	NULL
motifs	NULL
within	NULL
this	NULL
Biochemistry	NULL
:	NULL
Tuan	NULL
et	NULL
al	NULL
.	NULL

region	NULL
of	NULL
HS2	NULL
,	NULL
when	NULL
delivered	NULL
to	NULL
the	NULL
promoter	NULL
,	NULL
can	NULL
interact	NULL
fruitfully	NULL
with	NULL
the	NULL
promoter	NULL
binding	NULL
proteins	NULL
.	NULL

The	NULL
tandem	NULL
Apl	NULL
sites	NULL
may	NULL
drive	NULL
enhancer	NULL
function	NULL
also	NULL
by	NULL
a	NULL
looping	NULL
mechanism	NULL
.	NULL

In	NULL
transgenic	NULL
animals	NULL
,	NULL
an	NULL
apparent	NULL
competition	NULL
between	NULL
the	NULL
y	NULL
and	NULL
the	NULL
B-globin	NULL
transgene	NULL
for	NULL
binding	NULL
to	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
LCR	NULL
(	NULL
33	NULL
)	NULL
has	NULL
been	NULL
interpreted	NULL
to	NULL
result	NULL
from	NULL
alternative	NULL
loop	NULL
formation	NULL
(	NULL
34	NULL
)	NULL
between	NULL
the	NULL
y-	NULL
or	NULL
B-globin	NULL
promoter	NULL
and	NULL
the	NULL
LCR	NULL
.	NULL

As	NULL
Apl	NULL
factors	NULL
can	NULL
bend	NULL
the	NULL
target	NULL
site	NULL
(	NULL
35	NULL
)	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
the	NULL
HS2	NULL
enhancer	NULL
may	NULL
bend	NULL
at	NULL
the	NULL
tandem	NULL
Apl	NULL
sites	NULL
to	NULL
enable	NULL
more	NULL
upstream	NULL
DNA	NULL
to	NULL
loop	NULL
back	NULL
and	NULL
interact	NULL
with	NULL
the	NULL
far	NULL
downstream	NULL
globin	NULL
promoters	NULL
.	NULL

The	NULL
long	NULL
enhancer	NULL
transcripts	NULL
in	NULL
this	NULL
case	NULL
may	NULL
then	NULL
be	NULL
merely	NULL
incorrectly	NULL
initiated	NULL
upstream	NULL
transcripts	NULL
without	NULL
any	NULL
biological	NULL
function	NULL
.	NULL

So	NULL
far	NULL
,	NULL
direct	NULL
evidence	NULL
for	NULL
loop	NULL
formation	NULL
between	NULL
the	NULL
enhancer	NULL
and	NULL
the	NULL
promoter	NULL
sequences	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
prokaryotic	NULL
and	NULL
viral	NULL
systems	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

The	NULL
looping	NULL
model	NULL
of	NULL
enhancer	NULL
function	NULL
predicts	NULL
that	NULL
transcriptional	NULL
terminators	NULL
,	NULL
which	NULL
are	NULL
spliced	NULL
into	NULL
the	NULL
loop	NULL
region	NULL
to	NULL
block	NULL
tracking	NULL
or	NULL
transcription	NULL
through	NULL
the	NULL
loop	NULL
,	NULL
should	NULL
not	NULL
interfere	NULL
with	NULL
enhancer-promoter	NULL
interaction	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
enhancer-directed	NULL
activation	NULL
of	NULL
mRNA	NULL
transcription	NULL
.	NULL

Transcriptional	NULL
terminators	NULL
or	NULL
psoralen	NULL
pho-toadducts	NULL
inserted	NULL
between	NULL
an	NULL
upstream	NULL
yeast	NULL
or	NULL
viral	NULL
enhancer	NULL
and	NULL
the	NULL
cap	NULL
site	NULL
have	NULL
,	NULL
however	NULL
,	NULL
been	NULL
reported	NULL
to	NULL
block	NULL
mRNA	NULL
synthesis	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
Herendeen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
40	NULL
)	NULL
reported	NULL
that	NULL
a	NULL
viral	NULL
T4	NULL
enhancer	NULL
element	NULL
functions	NULL
primarily	NULL
by	NULL
a	NULL
tracking	NULL
mechanism	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
the	NULL
tracking	NULL
and	NULL
transcription	NULL
mechanism	NULL
of	NULL
HS2	NULL
enhancer	NULL
function	NULL
and	NULL
the	NULL
looping	NULL
mechanism	NULL
may	NULL
not	NULL
be	NULL
mutually	NULL
exclusive	NULL
.	NULL

The	NULL
transcriptional	NULL
machinery	NULL
assembled	NULL
at	NULL
the	NULL
tandem	NULL
Ap1	NULL
sites	NULL
in	NULL
the	NULL
HS2	NULL
enhancer	NULL
,	NULL
presumably	NULL
contains	NULL
the	NULL
Apl	NULL
factors	NULL
and	NULL
may	NULL
bind	NULL
tightly	NULL
to	NULL
the	NULL
enhancer	NULL
,	NULL
since	NULL
Apl	NULL
factors	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
grip	NULL
the	NULL
target	NULL
site	NULL
by	NULL
a	NULL
scissors-grip	NULL
mechanism	NULL
(	NULL
41	NULL
)	NULL
.	NULL

As	NULL
this	NULL
transcriptional	NULL
machinery	NULL
tracks	NULL
and	NULL
transcribes	NULL
the	NULL
DNA	NULL
,	NULL
it	NULL
may	NULL
bend	NULL
the	NULL
enhancer	NULL
onto	NULL
the	NULL
DNA	NULL
being	NULL
transcribed	NULL
and	NULL
bring	NULL
the	NULL
tightly	NULL
bound	NULL
enhancer	NULL
with	NULL
it	NULL
.	NULL

This	NULL
may	NULL
then	NULL
form	NULL
,	NULL
as	NULL
the	NULL
transcription	NULL
process	NULL
proceeds	NULL
,	NULL
an	NULL
increasingly	NULL
enlarging	NULL
loop	NULL
between	NULL
the	NULL
enhancer	NULL
and	NULL
the	NULL
DNA	NULL
bases	NULL
being	NULL
transcribed	NULL
and	NULL
finally	NULL
between	NULL
the	NULL
enhancer	NULL
and	NULL
the	NULL
promoter	NULL
sequences	NULL
.	NULL

In	NULL
DNA	NULL
replication	NULL
,	NULL
such	NULL
dynamic	NULL
loop	NULL
formation	NULL
by	NULL
a	NULL
tracking	NULL
mechanism	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
exist	NULL
between	NULL
the	NULL
ends	NULL
of	NULL
the	NULL
lagging	NULL
strand	NULL
and	NULL
the	NULL
DNA	NULL
at	NULL
the	NULL
advancing	NULL
replication	NULL
fork	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
tracking	NULL
and	NULL
transcription	NULL
mechanism	NULL
may	NULL
establish	NULL
the	NULL
initial	NULL
contacts	NULL
between	NULL
the	NULL
HS2	NULL
enhancer	NULL
and	NULL
the	NULL
promoter	NULL
sequences	NULL
and	NULL
between	NULL
their	NULL
respective	NULL
binding	NULL
proteins	NULL
for	NULL
possible	NULL
subsequent	NULL
loop	NULL
formation	NULL
between	NULL
these	NULL
elements	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
.	NULL

L.	NULL
Gehrke	NULL
,	NULL
P.	NULL
Auron	NULL
,	NULL
W.	NULL
Solomom	NULL
,	NULL
P.	NULL
LeBoulch	NULL
,	NULL
R.	NULL
Cavallesco	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
London	NULL
for	NULL
helpful	NULL
discussion	NULL
;	NULL
Dr.	NULL
S.	NULL
Jobbling	NULL
and	NULL
E.	NULL
Chen	NULL
for	NULL
providing	NULL
the	NULL
interleukin	NULL
1	NULL
sequencing	NULL
ladders	NULL
as	NULL
size	NULL
markers	NULL
;	NULL
M.	NULL
Lee	NULL
,	NULL
D.	NULL
Lee	NULL
,	NULL
and	NULL
C.	NULL
Venditti	NULL
for	NULL
technical	NULL
assistance	NULL
;	NULL
and	NULL
L.	NULL
Cobb	NULL
for	NULL
typing	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
Howard	NULL
Hughes	NULL
Research	NULL
Training	NULL
Fellowship	NULL
(	NULL
K.H	NULL
.	NULL
)	NULL

and	NULL
by	NULL
grants	NULL
from	NULL
Johnson	NULL
&	NULL
Johnson	NULL
and	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
HL	NULL
39948	NULL
)	NULL
.	NULL

1	NULL
.	NULL

Tuan	NULL
,	NULL
D.	NULL
,	NULL
Solomon	NULL
,	NULL
W.	NULL
,	NULL
Li	NULL
,	NULL
Q	NULL
.	NULL

&	NULL
London	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82	NULL
,	NULL
6384-6388	NULL
.	NULL

2	NULL
.	NULL

Forrester	NULL
,	NULL
W.	NULL
,	NULL
Takegawa	NULL
,	NULL
S.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
Stamatoyannopoulos	NULL
,	NULL
G.	NULL
&	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
,	NULL
10159-10177	NULL
.	NULL

3	NULL
.	NULL

Grosveld	NULL
,	NULL
F.	NULL
,	NULL
Assendelft	NULL
,	NULL
V.	NULL
,	NULL
Greaves	NULL
,	NULL
D.	NULL
&	NULL
Kollias	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
975-985	NULL
.	NULL

4	NULL
.	NULL

Tuan	NULL
,	NULL
D.	NULL
,	NULL
Abeliovich	NULL
,	NULL
A.	NULL
,	NULL
Lee-Oldham	NULL
,	NULL
M.	NULL
&	NULL
Lee	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
in	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
-	NULL
11223	NULL
Developmental	NULL
Control	NULL
of	NULL
Globin	NULL
Gene	NULL
Expression	NULL
,	NULL
eds	NULL
.	NULL

Stamatoyannopoulos	NULL
,	NULL
G.	NULL
&	NULL
Nienhuis	NULL
,	NULL
A	NULL
.	NULL

(	NULL
Liss	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

211-220	NULL
.	NULL

Tuan	NULL
,	NULL
D.	NULL
Y.	NULL
H.	NULL
,	NULL
Solomon	NULL
,	NULL
W.	NULL
B.	NULL
,	NULL
London	NULL
,	NULL
I.	NULL
M.	NULL
&	NULL
Lee	NULL
,	NULL
D.	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
2554-2558	NULL
.	NULL

_	NULL
Tuan	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Molecular	NULL
Biology	NULL
of	NULL
Haematopoiesis	NULL
,	NULL
eds	NULL
.	NULL

Sachs	NULL
,	NULL
L.	NULL
,	NULL
Abraham	NULL
,	NULL
N.	NULL
,	NULL
Wiedermann	NULL
,	NULL
C.	NULL
,	NULL
Levine	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Konwalinka	NULL
,	NULL
G.	NULL
(	NULL
Intercept	NULL
,	NULL
London	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

205-216	NULL
.	NULL

Curtin	NULL
,	NULL
P.	NULL
,	NULL
Liu	NULL
,	NULL
D.	NULL
,	NULL
Liu	NULL
,	NULL
W.	NULL
,	NULL
Chang	NULL
,	NULL
J.	NULL
C.	NULL
&	NULL
Kan	NULL
,	NULL
Y.	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
7082-7086	NULL
.	NULL

Ryan	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Behringer	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Martin	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Townes	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Palmiter	NULL
,	NULL
R.	NULL
D.	NULL
&	NULL
Brinster	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
314-323	NULL
.	NULL

Sorrentino	NULL
,	NULL
B.	NULL
,	NULL
Ney	NULL
,	NULL
P.	NULL
,	NULL
Bodine	NULL
,	NULL
D.	NULL
&	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
2721-2731	NULL
.	NULL

Talbot	NULL
,	NULL
D.	NULL
,	NULL
Philipsen	NULL
,	NULL
S.	NULL
,	NULL
Fraser	NULL
,	NULL
P.	NULL
&	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
2169-2178	NULL
.	NULL

Kioussis	NULL
,	NULL
D.	NULL
,	NULL
Vanin	NULL
,	NULL
E.	NULL
,	NULL
deLange	NULL
,	NULL
T.	NULL
,	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

&	NULL
Grosveld	NULL
,	NULL
F.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
306	NULL
,	NULL
662-666	NULL
.	NULL

Curtin	NULL
,	NULL
P.	NULL
,	NULL
Pirastu	NULL
,	NULL
M.	NULL
,	NULL
Kan	NULL
,	NULL
Y.	NULL
W.	NULL
,	NULL
Gobert-Jones	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Stephens	NULL
,	NULL
A.	NULL
D.	NULL
&	NULL
Lehmann	NULL
,	NULL
H.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

76	NULL
,	NULL
1554-1558	NULL
.	NULL

Driscoll	NULL
,	NULL
K.	NULL
,	NULL
Dobkin	NULL
,	NULL
C.	NULL
S.	NULL
&	NULL
Alter	NULL
,	NULL
B.	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
7470-7474	NULL
.	NULL

Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
332	NULL
,	NULL
697-701	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
Augereau	NULL
,	NULL
P.	NULL
&	NULL
Chambon	NULL
,	NULL
P.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
32	NULL
,	NULL
503-514	NULL
.	NULL

Echols	NULL
,	NULL
H.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
233	NULL
,	NULL
1050-1056	NULL
.	NULL

Wang	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Giaever	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
240	NULL
,	NULL
300-304	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
&	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
.	NULL

Okayama	NULL
,	NULL
H.	NULL
&	NULL
Berg	NULL
,	NULL
P.	NULL
(	NULL
1983	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

3	NULL
,	NULL
280-289	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

&	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5301	NULL
.	NULL

Melton	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Krieg	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Rebagliati	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
,	NULL
Zinn	NULL
,	NULL
K.	NULL
&	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1984	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12	NULL
,	NULL
7035-7056	NULL
.	NULL

Baron	NULL
,	NULL
M.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
591-602	NULL
.	NULL

Wu	NULL
,	NULL
J.	NULL
,	NULL
Grindlay	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Bushel	NULL
,	NULL
P.	NULL
,	NULL
Mendelsohn	NULL
,	NULL
L.	NULL
&	NULL
Allan	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1209-1216	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
245	NULL
,	NULL
371-378	NULL
.	NULL

Moi	NULL
,	NULL
P.	NULL
&	NULL
Kan	NULL
,	NULL
Y.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
9000-9004	NULL
.	NULL

Ney	NULL
,	NULL
P.	NULL
,	NULL
Sorrentino	NULL
,	NULL
B.	NULL
,	NULL
McDonagh	NULL
,	NULL
K.	NULL
&	NULL
Nienhuis	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
993-1006	NULL
.	NULL

Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Wall	NULL
,	NULL
L.	NULL
,	NULL
deBoer	NULL
,	NULL
E.	NULL
,	NULL
Grosveld	NULL
,	NULL
F.	NULL
&	NULL
Romeo	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
37-54	NULL
.	NULL

Hope	NULL
,	NULL
I	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Struhl	NULL
,	NULL
K.	NULL
(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
2781-2784	NULL
.	NULL

Chen	NULL
,	NULL
W.	NULL
&	NULL
Strahl	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
261-268	NULL
.	NULL

Stalder	NULL
,	NULL
J.	NULL
,	NULL
Groudine	NULL
,	NULL
M.	NULL
,	NULL
Dodgson	NULL
,	NULL
J.	NULL
,	NULL
Engel	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Weintraub	NULL
,	NULL
H.	NULL
(	NULL
1980	NULL
)	NULL
Cell	NULL
19	NULL
,	NULL
973-980	NULL
.	NULL

Gross	NULL
,	NULL
D.	NULL
&	NULL
Garrard	NULL
,	NULL
W.	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

57	NULL
,	NULL
159-197	NULL
.	NULL

Forrester	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Epner	NULL
,	NULL
E.	NULL
,	NULL
Driscoll	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Enver	NULL
,	NULL
T.	NULL
,	NULL
Brice	NULL
,	NULL
M.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
&	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1637-1649	NULL
.	NULL

Enver	NULL
,	NULL
T.	NULL
,	NULL
Raich	NULL
,	NULL
N.	NULL
,	NULL
Ebens	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
Costantini	NULL
,	NULL
F.	NULL
&	NULL
Stamatoyannopoulos	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
,	NULL
309-313	NULL
.	NULL

Choi	NULL
,	NULL
O.	NULL
R.	NULL
B	NULL
.	NULL

&	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
17-26	NULL
.	NULL

Kerppola	NULL
,	NULL
T.	NULL
&	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
317-326	NULL
.	NULL

Muller	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Sogo	NULL
,	NULL
J.	NULL
M.	NULL
&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
767-777	NULL
.	NULL

Wedel	NULL
,	NULL
A.	NULL
,	NULL
Weiss	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Popham	NULL
,	NULL
D.	NULL
,	NULL
Droge	NULL
,	NULL
P.	NULL
&	NULL
Kustu	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
486-490	NULL
.	NULL

Brent	NULL
,	NULL
R.	NULL
&	NULL
Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
312	NULL
,	NULL
612-615	NULL
.	NULL

Courey	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Plon	NULL
,	NULL
S	NULL
$	NULL
.	NULL

E.	NULL
&	NULL
Wang	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
45	NULL
,	NULL
567-574	NULL
.	NULL

Herendeen	NULL
,	NULL
D.	NULL
,	NULL
Kassavetis	NULL
,	NULL
G.	NULL
&	NULL
Geiduschek	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
256	NULL
,	NULL
1298-1303	NULL
.	NULL

Vinson	NULL
,	NULL
C.	NULL
,	NULL
Sigler	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

&	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
911-916	NULL
.	NULL

Brewer	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
679-686	NULL
.	NULL

